Understanding how certain genes that promote cell death are regulated in cancer cells
The Translational Regulation of Pro-apoptotic Genes
This study is looking at how a protein called pRB helps control the genes that tell cancer cells to die, and it aims to find new ways to make cancer treatments work better by understanding what happens when pRB is missing.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Ohio State University NIH-funded |
| Lab location | 1 site (Columbus, UNITED STATES) |
| Project ID | NIH-10977357 on NIH RePORTER |
What this research studies
This research investigates the mechanisms by which the Retinoblastoma 1 protein (pRB) influences the regulation of genes that promote cell death in cancer cells. It focuses on how the loss of pRB affects the expression and translation of pro-apoptotic genes, which are crucial for preventing uncontrolled cell growth. By profiling RNA and protein changes in cancer cells lacking pRB, the study aims to identify RNA-binding proteins that inhibit the translation of these important genes. The ultimate goal is to uncover new therapeutic targets that could enhance the effectiveness of cancer treatments by promoting cell death in cancerous cells.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients with cancers characterized by the inactivation of the Retinoblastoma 1 protein.
Not a fit: Patients whose cancers do not involve pRB inactivation may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new strategies for cancer treatment that effectively induce cell death in tumors lacking pRB.
How similar studies have performed: Previous research has shown promising results in targeting apoptotic pathways in cancer, suggesting that this approach could yield significant advancements.
Where this research is happening
Columbus, UNITED STATES
- Ohio State University — Columbus, United States (Active)
Researchers
- Principal investigator: Miles, Wayne — Ohio State University
- Study coordinator: Miles, Wayne
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.